This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Ranibizumab is noninferior to panretinal photocoagulation with regard to visual acuity outcomes at 2 ...
An injection of 6 mg of intravitreal brolucizumab was at least as effective as — and potentially superior to — panretinal laser photocoagulation in preserving vision in patients with proliferative ...
Efficient and accurate diagnosis of diabetic retinopathy, risk assessment, and treatment are critical, given the disease burden. Globally, from 1990 to 2010, visual impairment due to diabetic ...
Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...
The phase 3 CONDOR trial found brolucizumab superior to panretinal laser photocoagulation for proliferative diabetic retinopathy, offering better vision outcomes and disease regression. The anti-VEGF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results